单细胞鉴定、药敏试验与全基因组测序:临床抗菌药敏试验拉曼组学直接检测胃活检幽门螺杆菌
本研究介绍临床抗菌药敏试验拉曼组学方法CAST-R-HP,可直接从胃活检样本中以单细胞分辨率快速鉴定幽门螺杆菌、基于代谢抑制进行药敏试验,并对靶向耐药表型细胞进行全基因组测序。该方法在鉴定中达到98.5±0.27%准确率,对左氧氟沙星和克拉霉素药敏报告100%准确率。
要点
- CAST-R-HP可直接从胃活检样本中单细胞鉴定幽门螺杆菌,准确率98.5±0.27%。
- 基于代谢抑制水平报告左氧氟沙星和克拉霉素药敏,准确率100%。
- 可对靶向耐药表型单细胞进行全基因组测序,最大覆盖度99.70%。
核心结论
- CAST-R-HP无需培养、周转时间短、分辨率高且信息全面,是诊断和治疗幽门螺杆菌感染的有力工具。
研究设计与样本
- 本研究为方法学开发与临床样本验证研究,介绍CAST-R-HP方法并在临床样本中验证。
- 方法在单细胞分辨率下直接处理活检样本,完成快速鉴定、基于代谢抑制的药敏试验及靶向耐药表型细胞的全基因组测序。
主要发现
- 单细胞拉曼光谱自动采集与机器学习可从活检样本中区分单个幽门螺杆菌细胞,鉴定准确率为98.5±0.27%。
- 在拉曼光谱采集前加入48至72小时D2O喂养和药物暴露步骤,CAST-R-HP基于代谢抑制水平报告左氧氟沙星和克拉霉素药敏,准确率100%。
- 通过拉曼激活重力驱动细胞封装与测序,CAST-R-HP支持单细胞分选、低偏差DNA扩增及全基因组测序,全基因组突变图谱最大覆盖度99.70%。
临床怎么用
- CAST-R-HP可直接从胃活检样本进行幽门螺杆菌鉴定、药敏试验和耐药机制分析,无需培养。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The battle against Helicobacter pylori (H. pylori) infections demands fast, reliable, and sensitive methods for pathogen identification (ID), antimicrobial susceptibility tests (ASTs) based on metabolic response, and genome-wide mutation profiling that reveals resistance mechanisms. METHODS: Here we introduce Clinical Antimicrobial Susceptibility Test Ramanometry for H. pylori (CAST-R-HP), and its validation with clinical samples. This method performs rapid ID, metabolism inhibition-based AST, and high-quality whole-genome sequencing for cells of targeted resistance phenotype, all at precisely 1-cell resolution and directly from biopsy samples. RESULTS: In CAST-R-HP, automated acquisition and machine learning of single-cell Raman spectra (SCRS) enable distinguishing individual H. pylori cells directly from a biopsy sample, with 98.5 ± 0.27% accuracy in ID. Moreover, by adding a 48- to72-h D2O feeding and drug exposure step prior to SCRS acquisition, CAST-R-HP reports AST for levofloxacin and clarithromycin with 100% accuracy, based on metabolic inhibition level. Furthermore, CAST-R-HP supports rapid sorting, low-bias DNA amplification, and full genome sequencing of single H. pylori cells with the SCRS defined, targeted drug-susceptibility phenotype, via Raman-activated gravity-driven cell encapsulation and sequencing. The genome-wide mutation map (maximum 99.70% coverage), at precisely 1-cell resolution, not only elucidates the drug-susceptibility phenotypes but also unveils their underlying molecular mechanisms. CONCLUSION: The culture independency, shorter turnaround time, high resolution, and comprehensive information output suggest that CAST-R-HP is a powerful tool for diagnosing and treating H. pylori infections.
引用
- Liu M, Zhu P, Zhang L, et al. Single-Cell Identification, Drug Susceptibility Test, and Whole-genome Sequencing of Helicobacter pylori Directly from Gastric Biopsy by Clinical Antimicrobial Susceptibility Test Ramanometry. Clin Chem. 2022. PMID: 35714147. doi:10.1093/clinchem/hvac082
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。